in the news

Emergent Announces Additions to Leadership Team

Emergent is pleased to announce the addition of two senior leaders to its  CDMO and Quality & Compliance organizations.

Bill Hartzel is joining Emergent as Senior Vice President for CDMO effective March 14. Hartzel will lead Emergent’s CDMO business, reporting to Chief Operating Officer Adam Havey. Hartzel most recently served as Chief Commercial Officer for Woodstock Sterile Solutions. 

Effective April 1, Coleen Glessner will join Emergent as Executive Vice President with enterprise responsibility for the Global Quality and Ethics and Compliance functions reporting directly to the CEO, Robert Kramer. Glessner joins the company from Alexion Pharmaceuticals where she served as Senior Vice President and Chief Quality Officer.

Read the full announcement here.

Novavax + Emergent: In the news

Original news coverage of Novavax's agreement with Emergent BioSolutions to manufacture and develop an experimental oral vaccine...

READ MORE

Vaxart + Emergent: In the news

Original news coverage of Vaxart's agreement with Emergent BioSolutions to manufacture and develop an experimental oral vaccine...

READ MORE

Novavax agreement for Experimental Vaccine Candidate for Coronavirus Disease

GAITHERSBURG, Md., March 10, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has entered...

READ MORE